Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subglottic flurbiprofen for prevention of post-intubation laryngeal inflammation in cardiac surgery
2020-000886-17Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Post-extubation sore throat (POST) comparing Flurbiprofen with Placebo (2 arms). Primary endpoint: Incidence and intensity of postoperative sore throat. Started Oct 2020; status: completed.
02
Drugs
flurbiprofen
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on 2020-000886-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000886-17.